Switching to cyclosporine ophthalmic solution 0.09% improves signs and symptoms in patients with DED

In adults with dry eye disease that was not adequately controlled with cyclosporine ophthalmic emulsion 0.05%, switching to cyclosporine ophthalmic solution 0.09% was associated with statistically significant improvements in both signs and symptoms of dry eye over 12 weeks, according to a study. The single-arm, open-label trial, included adults with...